Schedule 13G ownership disclosure

XILIO THERAPEUTICS INC

Security class unavailable · CUSIP: 98422T100

Event date: 2021-10-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
20,234,021
Percent of class
7.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-21-010819
Form type
SC 13G
Filer
Atlas Venture Fund XI, L.P.
CIK
CIK 1708269
Filed
Nov 05, 2021
Reporting period
Oct 26, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub